Articles by PLOS

The compound, MK-8527, belongs to a novel class of antiretrovirals

Researchers following nearly 1,000 people with post-COVID-19 syndrome found few changes to their symptoms in the second year of illness

 About 60 of 400 Phase 2 and 3 cancer drug trials registered between 2016 and 2017 had suboptimal control arms

Presence of endogenous retrovirus RNA in non-diseased tissues could affect use as a cancer biomarker

Analyzing the genetic sequences and antibiotic susceptibility of more than 10,000 global M. tuberculosis isolates

A recent literature review helped researchers map out the spike protein mutations that resist antibody binding

Microbiome research is heavily biased in favor of wealthy countries such as US and UK

New study identifies mutations that may be worth deeper surveillance

False positive reactivity in earliest RT-PCR tests due to contamination and design errors

Authors identify a subset of journals where a few authors were responsible for a disproportionate number of publications

Almost two dozen genes that contribute to heart defects were identified

Study examines how to minimize new infections and hospitalizations with limited vaccine supply and distribution

Researchers made the discovery by exploring which genes were turned on and off in the hippocampus of patients

Researchers have developed two distinct, highly innovative AST methods for directly measuring a pathogen's susceptibility to beta-lactams on very short time scales

Rising antimicrobial resistance has already rendered some infections untreatable with existing drugs